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ALG-2 belongs to the penta-EF-hand (PEF) protein
family and interacts with various intracellular pro-
teins, such as Alix and TSG101, that are involved in
endosomal sorting and HIV budding. Through X-ray
crystallography, we solved the structures of Ca2+-
free and -bound forms of N-terminally truncated
human ALG-2 (des3-20ALG-2), Zn2+-bound form of
full-length ALG-2, and the structure of the complex
between des3-23ALG-2 and the peptide correspond-
ing to Alix799-814 in Zn2+-bound form. Binding of
Ca2+ to EF3 enables the side chain of Arg125, present
in the loop connecting EF3 and EF4, to move enough
to make a primary hydrophobic pocket accessible to
the critical PPYP motif, which partially overlaps with
the GPP motif for the binding of Cep55 (centrosome
protein 55 kDa). Based on these results, together
with the results of in vitro binding assay with mutant
ALG-2 and Alix proteins, we propose a Ca2+/EF3-
driven arginine switch mechanism for ALG-2 binding
to Alix.
INTRODUCTION
ALG-2 is an apoptosis-linked calcium-binding protein of 191
amino acid residues containing five serially repetitive EF-hand
motifs (EF1–EF5) in its C-terminal region, and belongs to the
penta-EF-hand (PEF) family, which includes the calpain small
subunit, sorcin, grancalcin, and peflin in mammals (reviewed by
Maki et al. [1997; 2002]). Among the mammalian PEF proteins,
ALG-2 has the shortest Gly/Pro-rich hydrophobic region (23 res-
idues) in itsN-terminal region.ALG-2was identifiedasaproapop-
totic protein of a mouse T-cell hybridoma, and it was found that
ALG-2 depletion by expression of its antisense mRNA protects
against cell death induced by several stimuli, such as glucocorti-
coids, T-cell receptors, and Fas triggering (Vito et al., 1996).
ALG-2hasbeenshown to interactCa2+-dependentlywith various
intracellular proteins containing Pro-rich regions, such as Alix
(also known as AIP1) (Missotten et al., 1999; Vito et al., 1999),1562 Structure 16, 1562–1573, October 8, 2008 ª2008 Elsevier LtdannexinsA7andA11 (Satoh et al., 2002a, 2002b), TSG101 (Katoh
et al., 2005), andphospholipid scramblase3 (Shibata et al., 2008).
AlthoughALG-2-deficientmice develop normallywith no obvious
abnormalities in the immune systems (Jang et al., 2002), it has
been suggested that ALG-2 and/or Alix have physiological roles
in regulation of ER-stress-induced apoptosis, neuronal cell death
during development, and cancer (Rao et al., 2004; reviewed by
Tarabykina et al. [2004]; Sadoul [2006]; Maki and Shibata
[2007]). Alix functions in the regulation of cell adhesion, apopto-
sis, endocytosis, multivesicular body formation, and budding of
enveloped RNA viruses (Morita and Sundquist, 2004; Odorizzi,
2006). Alix is a cytoplasmic 95 kDa protein containing Bro1 do-
main, V domain, and Pro-rich domain in the N-terminal, middle,
and C-terminal regions, respectively (Williams and Urbe´, 2007).
ALG-2 binds Alix in the C-terminal Pro-rich region at a site that
contains four tandem PxY repeats (Shibata et al., 2004). Simulta-
neous substitutions of all four prolines or tyrosines to alanines
caused loss of the binding ability, but it has remained unclear
which Pro or Tyr residues are critical for the interaction. An alter-
native splicing isoform lacking Gly121-Phe122, designated
ALG-2DGF122 in this article, does not bind Alix (Tarabykina et al.,
2000; Shibata et al., 2007, 2008).
X-ray crystal structures of PEF proteins have been solved for
calpain subunits (Blanchard et al., 1997; Lin et al., 1997; Hosfield
et al., 1999; Strobl et al., 2000) and their close homologs, such as
sorcin (Xie et al., 2001; Ilari et al., 2002) and grancalcin (Jia et al.,
2000, 2001a). Each PEF protein contains eight a helices and
forms a dimer via EF5. Although the crystal structure of the
Ca2+-bound form of elastase-treated mouse ALG-2 has also
been solved (Jia et al., 2001b), structures of the Ca2+-free form
and complexes with target peptides have remained unknown.
In the present study, we elucidate the crystal structures of the
Ca2+-free form, the Ca2+-bound form, the Zn2+-bound form,
and the Alix oligopeptide complex with either full-length or N-ter-
minal Gly/Pro segment-deleted human ALG-2. Based on a com-
parison of these structures and the results of in vitro binding
assays with mutant ALG-2 and Alix proteins, we postulate the
structural basis for the mechanism of Ca2+-dependent binding
of ALG-2 to Alix at the atomic level. Binding of Ca2+ to EF3 in-
duces rearrangement of the loop connecting EF3 and EF4, and
makes a hydrophobic pocket accessible to the primary binding
site of Alix peptide.All rights reserved
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Structure of ALG-2/Alix Peptide ComplexRESULTS AND DISCUSSION
For crystallization of human ALG-2, we prepared recombinant
proteins in the forms of full-length and two different mutants
with deletion in the N-terminal Gly/Pro-rich region (des3-
20ALG-2; des3-23ALG-2) (Figure 1). Crystallization conditions
were first screened with an automated robotic system (Hiraki
et al., 2006) and further optimizedmanually. All crystal structures
were solved by the molecular replacement method with the
program MOLREP (Vagin and Teplyakov, 1997), with the Ca2+-
bound structure of elastase-treated mouse ALG-2 (Jia et al.,
2001b) (Protein Data Bank [PDB] code 1HQV) as a searchmodel.
Data collection, processing, and refinement statistics are
summarized in Table S1 available online. Schematic secondary
structures and Ca2+-coordinating residues are shown alongside
the amino acid sequence in Figure S1.
Jia et al. (2001a; 2001b) previously compared the elucidated
crystal structure of Ca2+-bound mouse ALG-2 with the Ca2+-
free and -bound forms of grancalcin and calpain domain VI
(dVI; small subunit PEF domain). However, structural compari-
son between Ca2+-bound ALG-2 and either Ca2+-free grancalcin
or calpain dVI gave limited information, because ALG-2 belongs
to the group I PEF subfamily and it is evolutionarily distant from
members of the group II PEF subfamily that includes calpain sub-
units, grancalcin and sorcin (Maki et al., 2002). Vernarecci et al.
(2007) recently found by fluorescence photometric analyses that
the yeast homolog of ALG-2, Pef1p, binds both Ca2+ and Zn2+,
and that both ions induce conformational change of the protein.
Indeed, zinc ion was also found to be effective for human ALG-2
to interact with Alix peptide with a surface plasmon resonance
(SPR) biosensor (Figure S2).
Structures of Ca2+-Free, Ca2+-Bound,
and Zn2+-Bound ALG-2 Proteins
We investigated Ca2+- or Zn2+-induced conformational changes
by solving the structures of Ca2+-free and Ca2+-bound forms of
des3-20ALG-2 (PDB codes 2ZND and 2ZN9, respectively) and
the Zn2+-bound form of full-length ALG-2 (PDB code 2ZN8). In
agreement with the mouse ALG-2 crystal structure, calcium
ions were found in the loops of EF1, EF3, and EF5 of the human
des3-20ALG-2 crystal, and were coordinated at x, y, z, y, x,
and z positions, as summarized in Table 1. Water molecule at
thex canonical coordination position is absent in the EF3 struc-
ture. Among the PEF proteins, ALG-2 is unique in that its EF5
binds Ca2+ in a canonical coordination, except for the z posi-
tion. A fourth calcium atom is held by two Asn106 residues in
crystallographically symmetric ALG-2 molecules (data not
shown). Coordination of zinc ions in EF1 and EF3 is similar to
that of calcium ions, except that water molecule at thex canon-
ical coordination position is absent in the EF1 structure (Table 1).
An electron density map shows that there are two ions bound in
the EF5 loop region. Anomalous difference Fourier map at 1.0 A˚
wavelength X-ray, however, indicates that the ion coordinated at
the canonical x, y, z, and y positions is not Zn2+. Instead of
Zn2+, another ion is coordinated at x, y, z, and y positions.
Since the crystallization buffer contains sodium salt, the coordi-
nated ion at the canonical positions in EF5 may be Na+. Coordi-
nation of Na+ was indeed recently reported for Ca2+-free S100A2
crystal structure (Koch et al., 2008). On the other hand, the sec-Structure 16, 1562ond ion that binds to OD1D171 shows a strong anomalous signal
of Zn2+ (data not shown).
Ca2+- or Zn2+-Induced Conformational Changes
The structures aligned between human des3-20ALG-2 and
mouse des1-20ALG-2 have a root-mean-square deviation
(rmsd) value of 0.21 A˚ for Ca atoms from residues Ala21 to
Phe188, indicating extremely similar structures. On the other
hand, the aligned structures between the Ca2+-free and
Ca2+-bound form of human des3-20ALG-2 have an rmsd value
of 1.20 A˚ for Ca atoms from residues Gln25 to Ser189 (Figure S3).
The resolved overall structure of the Zn2+-bound form of
full-length ALG-2 is very similar to that of the Ca2+-bound form
of des3-20ALG-2, except for EF5s (rmsd, 0.76 A˚ for Ca atoms
from residues 26–189) (Figure S3). The N-terminal Gly/Pro-rich
region of full-length ALG-2 is not visible in the electron density
map.
As shown in Figures 2A–2C, canonical 12 residue EF-hand
Ca2+-coordinating loops are formed between two almost per-
pendicularly placed helices in EF1 (a1 and a2) and EF3 (a4 and
a5), whereas EF5 has two extra residue insertions in the loop
Figure 1. Schematic Representations of ALG-2 and Alix
Human ALG-2 has a Gly/Pro-rich N-terminal region followed by the PEF
domain containing five EF-hands (EF1–EF5) with eight a helices (a1–a8). The
first and second helices in each EF hand are alternatively named, for instance,
helix E1 and helix F1, respectively. An alternatively spliced isoform (lacking
Gly121-Phe122) is designated ALG-2DGF122 in this article. Recombinant
proteins of full-length ALG-2 and two types of N-terminal deletion mutants
(des3-20ALG-2 and des3-23ALG-2) were crystallized. Alix has three distinct
domains, named Bro1, V, and Pro-rich. A 16-mer synthetic oligopeptide of
the ABS in Alix (Alix ABS peptide) was used for cocrystallization.–1573, October 8, 2008 ª2008 Elsevier Ltd All rights reserved 1563
Structure
Structure of ALG-2/Alix Peptide ComplexTable 1. Bond Distance for the Divalent Ion Coordinate in ALG-2
EF1 EF3 EF5
Distance (A˚) Distance (A˚) Distance (A˚)
Ca2+ Zn2+ Ca2+ Zn2+ Ca2+ Zn2+
Position Atom des3-20a Fullb Atom des3-20 Full Atom des3-20 Full
x OD1D36 2.3 2.2 OD1D103 2.3 2.3 OD1D169 2.5 ND
y OD2D38 2.2 2.3 OD2D105 2.5 2.4 OD2D171 2.3 ND
z OGS40 2.8 2.5 OGS107 2.5 2.8 OD1D173 2.2 ND
y OV42 2.4 2.1 OM109 2.4 2.5 OW175 2.5 ND
x H2O 2.3 ND H2O ND 2.8 H2O 2.3 ND
z OE1E47 2.8 2.5 OE1E114 2.3 2.4 H2O 2.4 ND
OE2E47 2.6 2.8 OE2E114 2.5 2.8
a des3-20, Ca2+-bound form of des3-20ALG-2.
b Full, Zn2+-bound form of ALG-2.between antiparallel helices (a7 and a8). Small conformational
changes by Ca2+ are common to the crystal structures of PEF
proteins. Nevertheless, greater changes are observed in the
EF1 region of calpain dVI (Blanchard et al., 1997) and grancalcin
(Jia et al., 2001a). Comparison of the structure of the Ca2+-bound
form (magenta) and that of the Zn2+-bound form (green) with that
of the Ca2+-free form (cyan) reveals little difference in EF1
(Figure 2A), whereas there is 2.4 A˚ movement (Ca2+-bound
form) or 2.1 A˚ movement (Zn2+-bound form) of Phe122 Ca in a5
by superimposing the first helix in EF3 (Figure 2B). On the other
hand, while 3.5 A˚ movement of Phe188 Ca in a8 was observed in
the Ca2+-bound structure, little movement was observed in the
Zn2+-bound structure (Figure 2C). Thus, the structure of EF5 in
the Zn2+-loaded ALG-2 crystal resembles the structure of EF5
in the Ca2+-free des3-20ALG-2 crystal, reflecting the absence
of EF-hand-type coordination of Zn2+ in EF5 (Table 1).
As previously shown in the structure of Ca2+-bound mouse
ALG-2 (Jia et al., 2001b), human ALG-2 homodimers also form
large crevices between each monomer molecule (molecules Aand B) (Figure 2D). Alignment of each molecule A at a7 caused
a greater shift of molecule B in the Ca2+-bound form (magenta)
than in the Zn2+-bound form (green) when compared with the
Ca2+-free form (cyan). This is due to the effect of Ca2+ on EF5
structure. Although ALG-2 exhibits small Ca2+-induced confor-
mational changes, fluorescencephotometric analysespreviously
revealed that binding of Ca2+ to ALG-2 induces exposure of hy-
drophobic surfaces (Maki et al., 1998; Lo et al., 1999; Tarabykina
et al., 2000; Subramanian et al., 2004). Rearrangements of side
chains of residues from Phe122 to Arg125 may account for the
results of fluorescence analyses (see subsequent discussion).
Structure of ALG-2/Alix ABS Peptide Complex
We attempted cocrystalization of ALG-2 with a 16 residue
peptide of the ALG-2 binding site (ABS) in Alix (corresponding
to 799–814, Cys813 substituted with Ser to avoid oxidization;
Figure 1) in the presence of Ca2+, but good crystals were not ob-
tained. Instead, we cocrystallized des3-23ALG-2with the 16 res-
idue Alix ABS peptide in the presence of Zn2+ and solved theFigure 2. Comparison of Ca2+-Free and
Ca2+-Bound Forms and Zn2+-Bound Form
of ALG-2
(A–C) Structures of EF1 (A), EF3 (B), and EF5 (C)
of Ca2+-free form (cyan) and Ca2+-bound form
(magenta) of des3-20ALG-2 and Zn2+-bound
form (green) of full-length ALG-2 are superim-
posed and shown in ribbon representation in
side views and top views by aligning helices of
(A) a1 (E1), (B) a4 (E3), and (C) a7 (E5), respectively,
with the secondary structure matching program
in COOT. Calcium atoms and zinc atoms are
shown as yellow spheres and gray spheres,
respectively.
(D) Overall structures of dimeric ALG-2 molecules
in the three forms are aligned at a7 of molecule A
and shown in wire presentation. The N-terminal
Gly/Pro-rich region is invisible.
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Structure
Structure of ALG-2/Alix Peptide Complexstructure at 2.2 A˚ resolution (PDB code 2ZNE). Metal coordina-
tion of des3-23ALG-2 was the same as that of full-length ALG-2
in the Zn2+-bound form (PDB code 2ZN8). An asymmetric
unit of the crystal contains twoALG-2molecules (A andB) as a di-
mer, but, surprisingly, each ALG-2 molecule binds the Alix ABS
peptide in a different manner: molecule A binds one Alix ABS
peptide (C), whereas molecule B binds two partial Alix ABS pep-
tides (D and its crystallographic symmetry mate, D0). While
peptide C binds only molecule A, peptide D (and also peptide
D0) binds both molecules B and B0, which are related by crystal-
lographic two-fold symmetry (Figure 3A). The Alix ABS peptides
are seen in a groove composed of residues from the end of a3 to
themiddle of the loop between a7 and a8 (Figure 3B). The groove
of ALG-2 contains two distantly positioned peptide binding
pockets (pockets 1 and 2). Pocket 1 is formed by residues of
the a5-a6 loop and those from EF5 (from a7 to a8). Pocket 2 is
formed by residues from a3, a4, a5, and a7.
Hydrophobic interactions and hydrogen bonds between
ALG-2 molecules and Alix ABS peptides are summarized in
Figure 3C and in Table S2. All residues of peptide C, except for
the first one, are visible in the crystal. Residues 7-TYPG-10
and 14-YS-15 of peptide C do not interact with ALG-2 molecule
A (Figure 3D), but they are involved in intramolecular interactions
(Table S3); in addition, residues 7-TYPG-10 are involved in crys-
tal packing with molecule B (data not shown). The N-terminal
part (2-GPPYP-6) of peptide C, designated as site 1, binds
pocket 1, whereas the C-terminal part (11-YPG-13 and Q16) of
peptide C, site 2, binds pocket 2 of molecule A (Figure 3D). In
the case of peptide D, the last four residues, 13-GYSQ-16, are
invisible. The N-terminal 2-GPPYP-6 (site 1) of peptide D binds
pocket 1 of molecule B (Figure 3E). The C-terminal part of pep-
tide D comes off molecule B and goes toward the neighboring
molecule B0, and 8-YPGYPG-12 of peptide D, designated as
site 3, binds pocket 2 of molecule B0. Symmetrically, pocket 2
of molecule B accommodates site 3 of peptide D0.
The binding mode of the N-terminal part of the Alix peptide
(2-GPPYP-6; site 1) by pocket 1 of ALG-2 is almost identical in
both molecules of the dimer (Figures 3D and 3E and Figure S4
and Table S2). The side chain of R125 of ALG-2 blocks the groove
between the a5-a6 loop and thea7-a8 loop to complete pocket 1.
The peptide side chains of P3, P4, and P6 pack against the a7-a8
loop, R125 side chain, and the a5-a6 loop, respectively. The Y180
side chain from the counterpart molecule constitutes the bottom
of pocket 1 and accommodates the side chains of peptides P4
and Y5. On the other hand, the binding mode of the C-terminal
part of the Alix peptide bypocket 2 of ALG-2 shows significant dif-
ferences between two molecules of the dimer. When ALG-2 mol-
eculesAandBaresuperimposed,P12ofpeptideCandP9ofpep-
tide D0 occupy the same position in pocket 2, stacking against the
side chain of W95 of ALG-2. The Y11 residue of peptide C and Y8
residue of peptide D0 are accommodated in almost the same po-
sition of pocket 2; however, their side chains show different orien-
tations. These YP residues would be the consensus bindingmotif
for pocket 2. The conformation of peptides C terminal to this YP
motif largely differs between peptide C and D0. The backbone of
peptide C folds back at G13 against pocket 2, and Y14 and S15
do not interact with ALG-2. The side chain of Y14 faces against
P9 intramolecularly (Table S3). On the other hand, 10-GYP-12 of
peptide D0 extends along the surface of pocket 2 (Figure 3E).Structure 16, 1562Critical Residues in Alix and ALG-2 for Their Binding
To determine the contributions of individual amino acid residues
in Alix to interaction with ALG-2, we performed in vitro overlay
binding assays of various alanine-substituted GST-AlixABS-His
mutants (Figure 4A) with biotin-labeled ALG-2 (bio-ALG-2) as
a probe and GST-His as a negative control. As shown in Fig-
ure 4B, bio-ALG-2 binding signals were lost or significantly
reduced in the mutants at site 1, whereas mutations at sites
2 or 3 had smaller effects. Substitutions into glycines instead
of alanines at P9 and P12 had similar partial effects on binding
abilities (data not shown). Next, we investigated whether themu-
tations at site 1 were also crucial in the full-length Alix protein to
interact with ALG-2. Green fluorescent protein-fused Alix (GFP-
Alix) of wild-type (WT) and mutants (P802A, Y803A, and P804A,
corresponding to P4A, Y5A, and P6A, respectively) were tran-
siently expressed in HEK293T cells, and the proteins that were
immunoprecipitated with an anti-GFP antibody were separated
by SDS-PAGE, transferred to PVDF membranes, and then ana-
lyzed by Western blotting (Figure 4C, left panel) and bio-ALG-2
overlay assay (right panel), in which GFP served as a negative
control. Signals of the mutants were significantly reduced com-
pared with those of the WT, and only faint bands were observed.
Critical residues in ALG-2 were also investigated by GST-pull-
down assay. Substitutions of residues that make contact with
peptide C at site 1 in pocket 1 of ALG-2 (Y124, R125, D169,
and Y180) resulted in loss of binding abilities (Figure 4D). Among
the residues in pocket 2, the binding abilities were lost by muta-
tions of Y91 and W95, but augmented by mutations of M71 and
Q159. The alternatively spliced isoform, ALG-2DGF122, lacks the
ability to bind Alix, in agreement with previous reports (Taraby-
kina et al., 2000; Shibata et al., 2007, 2008). Deletion of F122
causes a significant decrease in binding to Alix, as determined
by SPR analysis (Subramanian et al., 2004). The side chain of
F122 interacts with Y11 of Alix peptide C, and carbonyl carbon
of G123 interacts hydrophobically with P6 Cd of peptide C (Table
S2), suggesting importance of these residues for Alix peptide
binding.
Ca2+/EF3-Driven Configuration Change
of Arg125 Side Chain
To understand in detail the structural basis for Ca2+-dependent
binding of ALG-2 to Alix ABS peptide, we compared the three
elucidated ALG-2 structures. Since site 1 is common to peptide
C (in molecule A) and peptide D (in molecule B) or D0 (in molecule
B0), and the 3-PPYP-6 sequence is critical for ALG-2 binding
(Figure 4B), we analyzed Ca2+-dependent rearrangements of
residues in Pocket 1 (Figure 5A, left panel, green). This hydro-
phobic pocket becomes open upon binding of Ca2+ to EF3, ex-
poses Y180 frommolecule B (Figure 5B, left panel, aquamarine),
and makes contact with 3-PPYP-6 (Figure 3D). The side chain of
R125 is exposed to a solvent, and its electron density is low in
the Ca2+-free form, suggesting flexibility of the residue. Upon
Ca2+ binding, the guanidino nitrogen atom of R125 forms a hy-
drogen bond with the peptide carbonyl oxygen atom of S120
(distance, 2.8 A˚) in such a way that the R125 side chain becomes
stabilized (Figure 5B, right panel). Moreover, an increase in the
distance between Y124 Cz and L158 Cg is observed (3.7 A˚ in
the Ca2+-free structure and 4.5 A˚ in the Ca2+-bound structure).
Upon Alix ABS peptide binding, pocket 1 is reclosed by the–1573, October 8, 2008 ª2008 Elsevier Ltd All rights reserved 1565
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Structure of ALG-2/Alix Peptide ComplexFigure 3. Crystal Structure of ALG-2/Alix ABS Peptide Complex
(A) Structure of two-fold symmetric ALG-2 tetramer (molecules A, A0, B, and B0 ) complexed with four peptide molecules with two different binding patterns
(peptides C, C0, D, and D0) is shown in wire representation of ALG-2 Ca, as well as superimposed transparent surface representation in green for molecule
A and cyan for molecule B, respectively. Peptides are shown in stick representation and colored magenta for peptide C and red for peptide D.
(B) Two monomers (molecules A and B) are shown in green and cyan in ribbon representation, respectively. The peptides are shown in magenta (peptide C), blue
(peptide D), and orange (peptide D0 ). EF-hand-coordinated zinc atoms are shown as gray spheres.
(C) Summary of ALG-2/peptide contact sites.
(D and E) Ribbon diagrams of the ALG-2/Alix ABS peptide complex in the monomeric ALG-2 molecule and stick representation of interacting residues. Carbon
atoms in ALG-2 molecules and Alix peptides are shown and colored similarly to (B). Carbon atoms of Y180 from the counter ALG-2 molecule are colored cyan (D)
1566 Structure 16, 1562–1573, October 8, 2008 ª2008 Elsevier Ltd All rights reserved
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Structure of ALG-2/Alix Peptide ComplexFigure 4. Mutational Analyses of Interactions between ALG-2 and Alix Peptide
Critical residues for interactions between ALG-2 and Alix were identified by site-specific mutagenesis.
(A) Alanine-scanning mutants of GST-fused Alix peptide were generated by inserting into a GST-His expression vector (control) each synthetic oligonucleotide
block encoding residues 3–14 of the Alix ABS peptide in which each Pro and Tyr was substituted with Ala.
(B) Purified proteins were subjected to overlay assay with bio-ALG-2. Relative binding abilities compared to WT were calculated and expressed in percentages.
The values obtained from triplicate experiments are expressed as means ± SD. A representative result is shown for the blot. CBB, Coomassie Brilliant Blue
staining.
(C) GFP-fused full-length Alix proteins of WT and amino acid-substituted mutants were expressed in HEK293T cells and subjected to Western blotting (WB) (left
panel) and bio-ALG-2 overlay assay (right panel) after immunoprecipitation with anti-GFP antibody. Unfused GFP was used as a negative control (Ctrl). Nonspe-
cific signals derived from IgG heavy chain are indicated by an asterisk.
(D) Endogenous Alix protein in HEK293 cells was pulled down with GST-fused WT, alternatively spliced isoform (DGF122), and single amino acid-substituted
mutants of ALG-2, as described in Experimental Procedures. Unfused GSTwas used as a negative control (Ctrl). Proteins bound to glutathione Sepharose beads
(pull-down products) were subjected to Western blotting with anti-Alix antibody. Input, 15%. (E) HEK293T cells were cotranfected with expression vectors for
Strep-tagged Alix of either WT, D795-841, or P802A mutant and FLAG-Cep55. Cleared lysates were subjected to pull-down assay with Strep-Tactin beads in
the presence of 5mMEGTA or 100 mMCaCl2. Proteins in the cleared lysates (input) and those bound to the beads (pull-down products) were analyzed byWestern
blotting with anti-FLAG monoclonal antibody (mAb), anti-Strep mAb and anti-ALG-2 polyclonal antibody, respectively.side chain of R125 (Figure 5C). Taken together, the Ca2+-depen-
dent binding of ALG-2 to Alix ABS peptide is explained as shown
in Figure 6: (1), change in geometry of helices E3 and F3 cause
detachment of the Y124 side chain from L158; (2) change in con-
figuration of the R125 side chain; (3) opening of pocket 1; (4)Structure 16, 1562entry of the peptide; and (5) half closure of pocket 1 by the
R125 side chain and completion of the peptide trapping. Thus,
R125 is a key element of the open-close mechanism of pocket
1, and acts as a switch driven by Ca2+/EF3 conformational
change.and green (E). Other atoms are also colored: nitrogen, blue; oxygen, red. The ALG-2 molecule is shown in gray in ribbon representation. Residues of Alix ABS
peptide that are involved in interaction with ALG-2 are indicated by asterisks above the sequence: (D) molecule A/peptide C; (E) molecule B/peptides D and
D0. Arrows indicate hydrophobic pockets (pockets 1 and 2).–1573, October 8, 2008 ª2008 Elsevier Ltd All rights reserved 1567
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Structure of ALG-2/Alix Peptide ComplexComparison with Published Structure of Ca2+-Bound
Mouse des1-20ALG-2
As shown in Figure S5, the configuration of R125 is significantly
different between the structure of human des3-23ALG-2/Alix
ABS peptide complex and the previously published structure
of mouse ALG-2 by Jia et al. (2001b) (PDB code 1HQV), in which
des1-20ALG-2 was thought to capture an N-terminal clipped
decapeptide 8-PGPGGGPGPA-17 that was obtained after elas-
tase treatment of full-length ALG-2. Hydrogen bonds and hydro-
phobic interactions are detected between R125 and Alix ABS
Figure 5. Structural Basis for Ca2+-Depen-
dent Binding of Alix Peptide to ALG-2
Structures of (A) Ca2+-free des3-20ALG-2, (B)
Ca2+-bound des3-20ALG-2, and (C) Alix peptide
C complex of des3-23ALG-2 coordinated with
Zn2+ are compared. Left panels: surface represen-
tation of molecule A. Residues of ALG-2 that hy-
drophobically interact with Alix peptide C at sites
1 and 2 are colored green (G123, Y124, R125,
T162, F165, Q172, G174) (pocket 1) and yellow
(M71, F72, Y91, D94, W95, F122, Q159) (pocket
2), respectively. Y180 from molecule B is colored
aquamarine. Alix ABS peptide is shown in ribbon
representation, and sites 1 and 2 are colored
magenta and pink, respectively, in (C). Right
panels: close-up views of pocket 1 and its vicinity
are shown in ribbon representation and in the stick
models for critical residues involved in opening of
pocket 1 or binding with Alix ABS peptide. Carbon
atoms are colored green for site 1 acceptor resi-
dues (Y124 and R125), yellow for a site
2 acceptor residue (F122), and orange for signal
transducing residues (L158 and S120). Carbon
atoms of Y180 from molecule B are colored in
cyan. Oxygen atoms and nitrogen atoms are in
red and blue, as indicated.
peptide (G2 and P4), and mutation of
R125 to alanine caused a loss of binding
ability to Alix (Figure 4D). On the other
hand, P8 and P10 of the N-terminal
ALG-2 decapeptide, positioned similarly
to G2 and P4 of Alix peptide in pocket 1,
are placed beyond the bonding distance
from R125 in 1HQV. Moreover, guanidino
group nitrogen of R125 forms a hydrogen
bond with carbonyl oxygen of S120, as in
the case of the Ca2+-bound but peptide-
free structure of human des3-20ALG-2
(Figure 5B).
Jia et al. (2001b) previously crystalized
the Ca2+-bound form of mouse des1-
20ALG-2with a buffer containing polyeth-
ylene glycol (PEG) 8000 after treatment of
full-length recombinant ALG-2 with elas-
tase. They found a continuous electron
density in a hydrophobic groove in the
solved ALG-2 structure, and interpreted
it as a Gly/Pro-rich decapeptide derived
from the cleaved N-terminus. We also
crystalized ALG-2 in the presence of PEG8000, but with geneti-
cally engineered N-terminally truncated des3-20ALG-2. Surpris-
ingly, we observed an electron density in a similar hydrophobic
groove in each ALG-2monomer (molecules A andB) in the asym-
metric unit (Figure S6). Mass spectrometric analyses of the
purified recombinant des3-20ALG-2 protein did not show signif-
icant signals in the 750–10,000 Da range (data not shown),
suggesting that no bacterial peptides were captured during
purification. By interpreting the continuous electron density as
a portion of PEG8000 molecule, we constructed a structural
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Structure of ALG-2/Alix Peptide ComplexFigure 6. Model of Ca2+/EF3-Driven Arginine Switch Mechanism
A proposed model of the arginine switch mechanism for Ca2+-dependent binding of ALG-2 to its target peptide. Left panel: In the Ca2+-free form, the flexible side
chain of R125 blocks themouth of the hyrophobic groove and interferes with entry of the target peptide. Middle panel: upon binding of Ca2+ to EF3, the side chain
of Y124 detaches from L158 and the guanidino nitrogen atom of R125 forms a hydrogen bond with the carbonyl oxgen atom of S120 in the distance of 2.8 A˚,
resulting in opening of the hydrophobic pocket. Right panel: a target peptide enters the pocket and is anchored there by interacting hydrophobically with
Y124 as well as with side chain carbon atoms of R125, resulting in a partial closure of the pocket. In stick representation, atoms of amino acid residues involved
in the arginine switch model are colored as follows: carbon, green for S120, Y124, and L158, and magenta for R125; oxygen, red; nitrogen, blue. Wire and ribbon
represent the main chain in gray and Alix ABS peptide in black, respectively.model of conjugated ethylene glycol oligomer, HO(CH2CH2O)nH,
residing in the hydrophobic groove including pockets 1 and 2
(molecule A, n = 9; molecule B, n = 11) (PDB code 2ZN9). How-
ever, we cannot exclude the possibility that the hydrophobic cleft
has a capacity to hold flexible hydrophobic peptides, including
the N-terminal region of ALG-2, with a low affinity. A higher ten-
dency of Ca2+-dependent aggregation of full-length ALG-2 than
N-terminal deleted ALG-2 at high concentrations of the ALG-2
proteins (Maki et al., 1998; Figures S2C–S2F) may be explained
by intermolecular interactions between the N-terminal segment
and the hydrophobic pockets.
Comparison with Other PEF Proteins
Although crystal structures of PEF family members have been
accumulating, comprehensive comparison between ALG-2
and other PEF proteins has not been done yet. In the present
study, it became possible to compare homodimers of ALG-2
and calpain dVI (PEF domain of small subunit) in three forms:
Ca2+-free form, Ca2+-bound form, and peptide-bound form. As
shown in Figure 7 and in Figure S7, difference in overall struc-
tures between ALG-2 and calpain dVI in each form becomes
apparent when antiparallel loops of EF5s (magenta) are placed
horizontally and compared with each other from three different
views (top, side, and bottom): (1) when projected onto the paper
surface (X-Y plane), the position of EF1 (cyan) relative to EF3
(green) is less rotated around the two-fold symmetric axis in
ALG-2 than in calpain dVI, counterclockwise in top view and
clockwise in bottom view, respectively; (2) the ALG-2 dimer
has a large crevice and less interacting surface between the
twomonomer molecules (calculated surface area buried at inter-
face: ALG-2/Ca2+, 2849 A˚2; calpain dVI/Ca2+, 4225 A˚2); and (3)
Alix ABS peptide binds to a hydrophobic groove formed by res-
idues from EF2 to EF5 in ALG-2 (top view and side view),
whereas calpastatin domain 1C peptide in an a-helical confor-
mation binds to a groove formed by EF1 and a hydrophobic
surface along F2E3 (side view and bottom view). The binding
surfaces for these peptides partly coincide with the area of
Ca2+-induced conformational rearrangement in helix F3 andStructure 16, 1562–F3E4 loop in ALG-2 (Figures 2, 5, and 6) and EF1 in calpain dVI
(Blanchard et al., 1997), respectively.
Regarding three-dimensional structures of grancalcin, the
Ca2+-free (apo) form and the form of Ca2+-bound at EF1 and
EF3 have been solved (Jia et al., 2001a). Superimposition of
both forms of grancalcin (red) with the respective form of ALG-2
(blue) at a7 helices shows a different arrangement of EF1/
EF2 relative to EF5 (Figure S8). Relative positions of EF3/EF4
segments in ALG-2 and grancalcin differ more in the Ca2+-free
forms than in the Ca2+-bound forms. The critical switch-acting
R125 in ALG-2 is conserved in grancalcin (R154) and sorcin
(R135), but not in other human PEF proteins (peflin, N216; m-cal-
pain large subunit, K650; calpain small subunit, H204). Compar-
ison of the configuration of the side chain of R154 in grancalcin
between their structures of the Ca2+-free and Ca2+-bound forms
shows that conformational movement is opposite to ALG-2
(Figures 5 and 8). Guanidino group nitrogen of R154 in grancalcin
forms a hydrogen bond with carbonyl oxygen of G149 in the
Ca2+-free form, and this latch is released in the Ca2+-bound
form. Interestingly, grancalcin associates with L-plastin, but
the complex dissociates in the presence of Ca2+ (Lollike et al.,
2001). It remains to be established whether this Ca2+-dependent
negative regulation of the interaction between grancalcin and
L-plastin is related to the Ca2+/EF3-driven arginine switch
mechanism proposed in the present study.
Regarding crystal structures of sorcin, only Ca2+-free forms
have been solved (Xie et al., 2001; Ilari et al., 2002). The side
chain configuration of sorcin R135 is not fixed due to greater B
factors (>70). Results of site-directed mutagenesis and a variant
protein suggest that sorcin is activated upon Ca2+ binding to EF3
and transmission of the conformational change at its loop via the
D helix (a4 helix) to EF2, and from there to EF1 via canonical
structural/functional pairing (Mella et al., 2003). Interestingly,
W105 in sorcin, which is located in the D helix and corresponds
to W95 in ALG-2, was found to be important for binding to
annexin A7 (Colotti et al., 2006). Substitution of W95 in ALG-2
with alanine also caused a loss of the binding ability to annexin
A7 (Shibata et al., 2008) aswell as Alix (Figure 4D). Although there1573, October 8, 2008 ª2008 Elsevier Ltd All rights reserved 1569
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Structure of ALG-2/Alix Peptide Complexis coincidence in the importance of W95 in ALG-2 and corre-
sponding W105 in sorcin for annexin A7 binding, the detailed
mode of binding may be different for the two PEF proteins,
because the N-terminal Gly/Pro-rich region is dispensable for
ALG-2 (Satoh et al., 2002b), but essential for sorcin (Verzili
et al., 2000).
ALG-2 Binding Motif
Although exact binding sites are not yet known, several other
ALG-2-binding proteins also contain sequences rich in Pro, Gly,
and Tyr, such as annexin A7 (4-PGYPPTGYPP-15), annexin
A11 (4-PGYPPPPGGYPP-15), and TSG101 (188-CPYPPGGP
YPA-198), suggesting a consensus sequence PPYP(X3–5)YP
(whereX is unchargedaminoacid).Optimumsequenceandnum-
ber of residues between two YPs may depend on surrounding
residues. Sec31AandScotin, however, donot conform to this se-
quence, but they also contain a segment rich in Pro and Tyr, such
as 869-PPYPQPQPYQP-877 in Sec31A and 190-PYPMQYPPP
Figure 7. Structural Comparison between ALG-2 and Calpain dVI in
Peptide Complex Forms
Dimeric structures are compared between ALG-2 and the PEF domain of
calpain small subunit (dVI) in the complex with respective target peptide
(ALG-2/Zn2+/Alix peptide, present study; calpain dVI/Ca2+/calpastatin pep-
tide, Todd et al., 2003). Structures are represented in transparent surface
superimposed with ribbon representation. EF1, cyan; EF3, green; EF5, ma-
genta; Alix ABS peptide, blue; calpastatin domain 1C peptide, red. Symmetric
two-fold axes of PEF dimers are perpendicular to the paper surface in top view
and bottom view.1570 Structure 16, 1562–1573, October 8, 2008 ª2008 Elsevier LtdYP-200 in Scotin, respectively. Recently, we identified two differ-
ent types of ABSs in the N-terminal Pro-rich region of phospho-
lipid scramblase 3: Alix type, 8-KGYAPSPPPPYPVTPGYPE
PA-28, and non-Alix type, 41-QVPAPAPGFALFPSPGPVA-61
(Shibata et al., 2008). While the Alix-type sequence binds to
ALG-2 but lacks the ability to bind ALG-2DGF122, the non-Alix
type binds to both isoforms of ALG-2. Sec31A also binds to
ALG-2DGF122 (Shibata et al., 2007), but its binding site has not
been identified yet. ALG-2 may present flexible binding surfaces
to various proteins with broad specificities and different affinities,
and probably even to PEG.
Recently, Cep55 (centrosome protein 55 kDa) was reported to
bind both Alix and TSG101 and to regulate cytokinesis by recruit-
ing ESCRTs (Carlton and Martin-Serrano, 2007; Morita et al.,
2007; Carlton et al., 2008). The proposed Cep55-recognition se-
quence in Alix, 800-GPP-802, partially overlaps with the ALG-2-
binding motif. As shown in Figure 4E, the single amino acid sub-
stitution mutant of Alix P802A abrogated FLAG-Cep55 binding,
and significantly reduced ALG-2 binding by the pull-down assay
with Strep-Alix expression constructs. The presence of Ca2+ in
the binding buffer caused a slight decrease in FLAG-Cep55
binding compared with the presence of EGTA, but the degree
of the decrease seems to be dependent on levels of exogenously
expressed FLAG-Cep55 and Strep-Alix in the repeated experi-
ments (data not shown). Although further investigation is
Figure 8. Side Chain Configuration of Conserved Arginine in the
F3-E4 Loop of Grancalcin and Sorcin
In the proposed arginine switch model of ALG-2, three other residues (S120,
Y124, and L158) are involved in addition to R125. Configurations of the corre-
sponding residues in grancalcin ([A] Ca2+-free form, PDB code 1K95; [B]
Ca2+-bound form, 1K94) and in sorcin ([C and D] Ca2+-free form; C, 1GJY;
D, 1JUO) are shown. Atoms are colored red, oxygen; blue, nitrogen. Carbons
inmolecule A, green;molecule B,magenta;molecule C, aquamarine;molecule
D, orange. Side chain of R135 in molecule A of sorcin in 1JUO is invisible.All rights reserved
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Structure of ALG-2/Alix Peptide Complexnecessary to evaluate the effect of Ca2+ on the binding efficiency
of Cep55, ALG-2 may play a role as an auxiliary factor in regulat-
ing biological functions in which Alix and ESCRTs are required in
conjunction with Ca2+ signaling.
In conclusion, in the present study, we have clarified the struc-
tural basis for the Ca2+-dependent binding of ALG-2 to Alix by
crystal structural analyses. Compared with other PEF proteins
described above (Figure 7; Figures S7 and S8) and with calmod-
ulin (Supplemental Results and Discussion), ALG-2 has a unique
activation mechanism. Binding of Ca2+ to EF3 induces rear-
rangement of R125 present in the loop connecting EF3 and
EF4, and makes a hydrophobic pocket accessible to PPYP,
the primary binding site of Alix peptide. We propose a Ca2+/
EF3-driven arginine switch mechanism.
EXPERIMENTAL PROCEDURES
Expression Plasmids
Bacterial expression ofN-terminally truncated humanALG-2 that lacks theGly/
Pro-rich region, designated ALG-2DN23, was described previously (Satoh
et al., 2002a), and this protein is renamed des3-23ALG-2 here. Construction
of an expression plasmid of des3-20ALG-2 and point mutations of the expres-
sionplasmids forGST-ALG-2andGFP-AlixwereperformedwithaQuikChange
Site-DirectedMutagenesis kit (Stratagene, USA). A control expression plasmid
ofGST-His containing twoflexibleGGS linkers betweenGSTandmultiple clon-
ing site and between multiple cloning site and 83 His, designated pGST-His,
was constructed by inserting two pairs of double-stranded oligonucleotides
into pET42b(+) (Invitrogen) by two-step insertions: first step: 50-CTAGTGGT
GGCTCAGGTGGTTCTGGTGGCTCAGCCGGTTCGGCAGG-30 and 50-AATTC
CTGCCGAACCGGCTGAGCCACCAGAACCACCTGAGCCACCA-30 into the
SpeI/EcoRI site; second insertion: 50-AATTCTTGCCTCGGCGGCAGGTTCAG
GTGGTTCTGGTGGCTCAC-30 and 50-TCGAGTGAGCCACCAGAACCACCTG
AACCTGCCGCCGAGGCAAG-30 into the SmaI/HindIII site. GST-fusion pro-
teins containing the ALG-2 binding sequence and its mutant sequences
were constructed by inserting double-stranded oligonucleotides into the
BglI-digested larger fragment of pGST-His.
Purification of Recombinant ALG-2 Proteins
and GST-Fused Alix Peptides
For X-ray crystallographic analyses, ALG-2 or deletion mutant ALG-2 proteins
were expressed and purified essentially as described previously with an
affinity column immobilizing an ALG-2 binding oligopeptide of phospholipid
scramblase 3 (Shibata et al., 2008). Purified proteins were concentrated to
about 10 mg/ml with a vacuum centrifuge evaporator (Sakuma, Japan). The
concentrated proteins were dialyzed against 10 mM Tris-HCl, pH 7.5, contain-
ing 10 mM each of EDTA and EGTA. For GST pull-down assay, GST fusion
proteins were expressed and purified with glutathione Sepharose beads (GE
Healthcare) according to the manufacturer’s instructions. For biotin-overlay
assay, GST-His or GST-AlixABS-His proteins were purified first with TALON
beads (Clontech) according to manufacturer’s instructions, and then further
purified with glutathione Sepharose beads.
Crystallization
All crystals, except for the divalent ion-free form of des3-20ALG-2, were grown
by the sitting or hanging drop vapor diffusion method at 20C. Full-length ALG-
2 protein was crystallized with 25% (w/v) 2-methyl-2, 4-pentanediol (MPD),
100mM sodium cacodylate, pH 6.5, and 75mM zinc acetate. The Ca2+-bound
form of des3-20ALG-2 was crystallized with 18% (w/v) PEG8000, 100 mM
sodium cacodylate, pH 6.5, and 200 mM calcium acetate. The Ca2+-free
form of des3-20ALG-2 was crystallized with 40% MPD, 100 mM Na2HPO4-
KH2PO4, pH6.5, and 2 mM EDTA at 4
C, as described previously (Wu et al.,
2001). The concentrated des3-23ALG-2 was added to the Alix peptide
(Alix799-814: QGPPYPTYPGYPGYSQ, Cys813 substituted with Ser to avoid
oxidization, purchased from Biosynthesis Inc., USA) with the protein-to-pep-Structure 16, 1562tide molar ratio of 1:2 and crystallized with 10% (v/v) 2-propanol, 100 mM ca-
codylate, pH 6.5, and 200 mM zinc acetate.
Data Collection, Structure Determination,
Refinement, and Analyses
All data were collected at beamlines BL-5A, 6A, and 17A of Photon Factory
(Tsukuba, Japan) under cryogenic conditions with crystals soaked in a cryo-
protectant solution containing 20% glycerol and cooled to 100K in a nitrogen
gas stream. The diffraction data were integrated and scaled with the HKL2000
program package (Otwinowski and Minor, 1997). All crystal structures were
solved by the molecular replacement method with the program MOLREP
(Vagin and Teplyakov, 1997) with the structure of elastase-treated mouse
ALG-2 (PDB code 1HQV) as a search model. All models were refined with
the programs CNS (Bru¨nger et al., 1998) and REFMAC5 (Murshudov et al.,
1997). Manual adjustments of the model were performed with COOT (Emsley
and Cowtan, 2004). All of the structural figures were generated with PyMol
(DeLano Scientific LLC, Palo Alto, CA). Rmsd was calculated with the program
CNS.
Bio-ALG-2 Overlay Assay and Pulldown Assays
Recombinant full-length ALG-2 was labeled with biotin in vitro with sulfosucci-
nimidylN-(D-biotinyl)-6-aminohexanoate (Biotin-AC5 Sulfo-OSu) as described
previously (Shibata et al., 2008). Overlay assay with bio-ALG-2 was per-
formed essentially as described previously (Shibata et al., 2008), but modi-
fied by incubating the membranes with horseradish peroxidase-conjugated
streptoavidin in TBS-T (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1%
Tween-20) containing 100 mM CaCl2, 0.1% gelatin, 10 mM 2-mercaptoether-
nol and 1 mM NiCl2 at 37
C for 1 hr. Signals were detected by the chemilu-
minescence method and analyzed with LAS-3000mini (Fuji Film, Tokyo, Ja-
pan). Inclusion of 1 mM NiCl2 was found to be effective for suppressing
nonspecific binding to GST-His protein (a negative control). For the detection
of ALG-2 binding to full-length Alix WT and mutant proteins that were fused
with GFP, GFP-Alix proteins were transiently expressed in HEK293T cells
and immunoprecipitated with rabbit anti-GFP antiserum (Invitrogen), as de-
scribed previously (Shibata et al., 2008), and then bio-ALG-2 overlay assay
was performed as described above. GST pull-down assay for ALG-2 binding
to endogenous Alix protein was performed as described previously (Shibata
et al., 2008) with an anti-Alix polyclonal antibody (Shibata et al., 2007). A hu-
man Cep55 cDNA was obtained from OpenBiosystems and subcloned into
a pCMV-Tag2B vector, and a pull-down assay with Strep-Alix was performed
essentially as described previously (Ichioka et al., 2007).
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